Literature DB >> 23690300

Child neurology: diagnosis of Lambert-Eaton myasthenic syndrome in children.

Bethanie Morgan-Followell1, Emily de Los Reyes.   

Abstract

OBJECTIVE: To report a case of Lambert-Eaton myasthenic syndrome (LEMS) in a child and review the existing literature of LEMS in children.
METHODS: We report a pediatric case of LEMS with the classic clinical triad of proximal weakness, autonomic dysfunction, and areflexia; the characteristic increment in compound motor action potential on high-frequency repetitive nerve stimulation; and positive serum P/Q-type voltage-gated calcium channel antibodies. Only 11 pediatric cases of LEMS have been reported in the literature.
RESULTS: The patient's presentation with LEMS led to the diagnosis of occult neuroblastoma. Based on review of the existing pediatric literature, no consistent clinical or electrodiagnostic criteria exist to diagnose LEMS in children.
CONCLUSIONS: There exists a need for consistent clinical criteria and electrodiagnostic testing for prompt diagnosis of LEMS in children. Prompt identification of LEMS will alert the physician to search for malignancy or another immune-mediated process.

Entities:  

Mesh:

Year:  2013        PMID: 23690300     DOI: 10.1212/WNL.0b013e318293e14e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

1.  Incidence and Ocular Features of Pediatric Myasthenias.

Authors:  Sasha A Mansukhani; Erick D Bothun; Nancy N Diehl; Brian G Mohney
Journal:  Am J Ophthalmol       Date:  2019-01-14       Impact factor: 5.258

2.  Sympathetic innervation controls homeostasis of neuromuscular junctions in health and disease.

Authors:  Muzamil Majid Khan; Danilo Lustrino; Willian A Silveira; Franziska Wild; Tatjana Straka; Yasmin Issop; Emily O'Connor; Dan Cox; Markus Reischl; Till Marquardt; Dittmar Labeit; Siegfried Labeit; Evelyne Benoit; Jordi Molgó; Hanns Lochmüller; Veit Witzemann; Isis C Kettelhut; Luiz C C Navegantes; Tullio Pozzan; Rüdiger Rudolf
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-05       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.